Old Web
English
Sign In
Acemap
>
authorDetail
>
Tamar E. Boursalian
Tamar E. Boursalian
Novo Nordisk
Insulin
Type 1 diabetes
Immunology
Diabetes mellitus
Endocrinology
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Expansion of Functional Regulatory T Cells Using Soluble RAGE Prevents Type 1 Diabetes
2020
bioRxiv
Sherman S. Leung
Danielle J. Borg
D. McCarthy
Tamar E. Boursalian
Justen Cracraft
Aowen Zhuang
Amelia K. Fotheringham
Nicole B. Flemming
Thomas S. Watkins
John J. Miles
Per-Henrik Groop
Jean L. J. M. Scheijen
Casper G. Schalkwijk
Raymond J. Steptoe
Kristen J. Radford
Mikael Knip
Josephine M. Forbes
Show All
Source
Cite
Save
Citations (1)
Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes
2017
Journal of Autoimmunity
Anna Ke Rydén
Nikole R. Perdue
Philippe P. Pagni
Claire B. Gibson
Sowbarnika S. Ratliff
Rikke K. Kirk
Travis J. Friesen
Claus Haase
Ken Coppieters
Matthias von Herrath
Tamar E. Boursalian
Show All
Source
Cite
Save
Citations (22)
Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouse.
2016
Clinical Immunology
Minh N. Pham
Claire B. Gibson
Anna Ke Rydén
Nikole R. Perdue
Tamar E. Boursalian
Philippe P. Pagni
Ken Coppieters
Christian Skonberg
Trine Porsgaard
Matthias von Herrath
Jose Luis Vela
Show All
Source
Cite
Save
Citations (11)
Traitement du diabète de type 1 à l'aide de glp-1 et d'anti-il-21
2015
Ken Coppieters
Matthias von Herrath
Tamar E. Boursalian
Show All
Source
Cite
Save
Citations (0)
1